Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.
Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
The investigator tested the efficacy of maraviroc intensification on down-regulating
atherosclerotic progression in HIV infected patients with optimal viro-immunologic control
and at high cardiovascular risk.